Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
RARE US​

Ultragenyx Pharmaceutical Inc.(RARE US)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income Statement

Balance Sheet

Cash Flow
Millions USD (ex. Per Share)
FY201112/31/2011
FY201212/31/2012
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Cash and Cash Equivalents213.6173.7434.0175.0
Short Term Investments363.6436.3259.0238.0
Cash and Short Term Investments577.2610.0693.0413.0
Net Receivables73.4121.8159.0121.0
Inventory34.045.052.055.0
Other Current Assets47.640.347.068.0
Total Current Assets732.2817.1951.0657.0
Property, Plant & Equipment290.6265.9267.0239.0
Long Term Investments199.9135.059.0127.0
Other Non-Current Assets57.762.735.055.0
Total Non-Current Assets758.8686.3581.0639.0
Total Assets1,491.01,503.51,532.01,296.0
Account Payables42.138.831.042.0
Short Term Debt--81.072.0
Deferred Revenue----
Other Current Liabilities142.887.5183.0211.0
Total Current Liabilities280.4344.2384.0325.0
Long Term Debt--1,171.01,128.0
Other Non-Current Liabilities904.6836.9-4.042.0
Total Non-Current Liabilities935.2897.01,221.01,200.0
Total Liabilities1,215.61,241.21,605.01,525.0
Common Stock0.10.1--
Retained Earnings-3,387.7-3,956.8-4,532.0-4,717.0
Total Stockholders Equity275.4255.3-80.0-236.0
Total Liabilities and Equity1,491.01,503.51,532.01,296.0